跳至主要内容
临床试验/JPRN-UMIN000001122
JPRN-UMIN000001122已完成3 期

An open-label, randomized, controlled study of peginterferon alpha-2a/ribavirin plus meloxicam treatment for the patients with genotype 1 chronic hepatitis C (COMET study) - Peginterferon alpha-2a/ribavirin plus meloxicam treatment for chronic hepatitis C (COMET study)

Tokai University School of Medicine0 个研究点目标入组 60 人开始时间: 2008年4月19日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) pregnant women (2) patients allergic to ribavirin or IFN (3) patients with uncontrolled heart diseases (4) patients with abnormal hemoglobin (5) patients with chronic renal diseases (6) patients with severe depression or mental illness (7) patinets with liver cirrhosis or liver failure (8) patients who can not discontinue other antiviral or immunomodulating drugs

研究者

相似试验